The increase of total activity of both ADA isoenzymes (tADA) in plasma of MS patients compared to healthy subjects (Figure 1A) resulted from enhanced ADA1 activity (Figure 1B), whereas no significant differences were observed in ADA2 activity (Figure 1C). This evidence concerns the gene ADA and myeloid sarcoma.